Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

Update

Fig. 04 -

Thyrotoxicosis Diagnosis

Fig. 05 -

AITD vs Graves' Disease

Fig. 06 -

When to Test

Fig. 07 -

Case 1

Fig. 08 -

Etiology

Fig. 09 -

I-123 Scan

Fig. 10 -

Thyrotoxicosis

Fig. 11 -

Etiology: 2016 Update

Fig. 12 -

GD Presentation

Fig. 13 -

Epidemiology – GD

Fig. 14 -

Antibodies

Fig. 15 -

Thyroid Autoantibodies

Fig. 16 -

TSH-R Antibody

Fig. 17 -

Impact

Fig. 18 -

Color Flow Doppler

Fig. 19 -

Thyroid Inferno

Fig. 20 -

Thyroid Inferno cont.

Fig. 21 -

Treatment

Fig. 22 -

Beta-blockers

Fig. 23 -

Treatment

Fig. 24 -

Treatment Long Term

Fig. 25 -

Antithyroid Drugs

Fig. 26 -

MMI versus PTU

Fig. 27 -

Baseline

Fig. 28 -

Favorable Prognostic Factors

Fig. 29 -

Mechanism

Fig. 30 -

Duration

Fig. 31 -

Duration 2016 Update

Fig. 32 -

After 12-18 months

Fig. 33 -

After 18 months

Fig. 34 -

After 22 months

Fig. 35 -

Case 1 Summary

Fig. 36 -

Surgery

Fig. 37 -

Surgery as Treatment

Fig. 38 -

Surgery: 2016 Update

Fig. 39 -

Surgery (cont)

Fig. 40 -

Radioiodine

Fig. 41 -

Case 2

Fig. 42 -

Pregnancy

Fig. 43 -

Teratogenesis

Fig. 44 -

Danish Nationwide Study

Fig. 45 -

Birth Defects

Fig. 46 -

Hyperthyroidism

Fig. 47 -

Planning a Pregnancy

Fig. 48 -

Insufficient Evidence

Fig. 49 -

Therapy Before Pregnancy

Fig. 50 -

Surgery vs Radioiodine

Fig. 51 -

TRAb during Pregnancy

Fig. 52 -

TRAb

Fig. 53 -

Utility of TSH-R-Ab

Fig. 54 -

Surgery during Pregnancy

Fig. 55 -

Post-Partum Thyrotoxicosis

Fig. 56 -

Case 3

Fig. 57 -

Labs Ordered

Fig. 58 -

3 Months Later

Fig. 59 -

Case 3 Summary

Fig. 60 -

Orbitopathy

Fig. 61 -

Summary